Package Leaflet: Information for the User
Tadalafil Krka 5 mg film-coated tablets EFG
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Tadalafil Krka contains the active substance tadalafil, which belongs to a group of medications called phosphodiesterase type 5 inhibitors.
Tadalafil Krka 5 mg is used to treat adult men with:
After sexual stimulation, Tadalafil Krka acts by helping to relax the blood vessels in the penis, allowing blood flow to the penis. The result is an improvement in erectile function. Tadalafil will not help if you do not have erectile dysfunction. It is essential to note that Tadalafil Krka is not effective if there is no sexual stimulation. Therefore, you and your partner should stimulate each other in the same way as you would if you were not taking a medication for erectile dysfunction.
Do not take Tadalafil Krka if
Warnings and precautions
Consult your doctor or pharmacist before starting to take Tadalafil Krka.
Be aware that sexual activity carries a possible risk in patients with heart problems, due to the additional effort it requires for the heart. If you have a heart problem, consult your doctor.
Since benign prostatic hyperplasia and prostate cancer can have the same symptoms, your doctor will perform a prostate cancer screening before starting treatment with tadalafil for benign prostatic hyperplasia.
Tadalafil Krka does not treat prostate cancer.
Before taking the tablets, inform your doctor if you have:
It is not known if tadalafil is effective in patients who have undergone:
If you experience a sudden decrease or loss of vision or your vision is distorted, blurred while taking tadalafil, stop taking this medication and contact your doctor immediately.
A sudden decrease or loss of hearing has been observed in some patients taking tadalafil. Although it is not known if the event is directly related to tadalafil, if you experience a sudden decrease or loss of hearing, stop taking this medication and contact your doctor immediately.
Tadalafil Krka 5 mg is not intended for use in women.
Children and adolescents
Tadalafil is not recommended in children or adolescents under 18 years of age.
Other medications and Tadalafil Krka
Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
Do not take Tadalafil Krka if you are already using nitrates.
Some medications may be affected by tadalafil or may affect the proper functioning of tadalafil. Inform your doctor or pharmacist if you are taking:
Taking Tadalafil Krka with beverages and alcohol
Information about the effect of alcohol can be found in section 3.
Grapefruit juice may affect the proper functioning of tadalafil and should be taken with caution. Consult your doctor for more information.
Fertility
In dogs treated with tadalafil, a decrease in sperm production by the testicles was observed. A reduction in sperm has been observed in some men. It is unlikely that these effects will produce a lack of fertility.
Driving and using machines
Some men who took tadalafil during clinical trials experienced dizziness. Carefully check how you react when taking the tablets before driving or using machines.
Tadalafil Krka contains lactose and sodium
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially "sodium-free".
Follow the administration instructions of this medication indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Tadalafil Krka 5 mg tablets are for oral administration only in men. Swallow the tablet whole with a little water. The tablets can be taken with or without food.
Consuming alcohol may affect your ability to have an erection and may temporarily lower your blood pressure. If you have taken or are planning to take Tadalafil Krka, avoid excessive alcohol consumption (blood alcohol level of 0.08% or higher), as it may increase the risk of dizziness when standing up.
For the treatment of erectile dysfunction
The recommended doseis one 5 mg tablet once a day, approximately at the same time. Your doctor may adjust the dose to 2.5 mg based on your response to tadalafil. This will be done by taking a 2.5 mg tablet. Alternatively, the 2.5 mg dose can be obtained by dividing the 5 mg tablet into two equal halves.
Do not take Tadalafil Krka more than once a day.
Tadalafil Krka administered daily allows you to achieve an erection at any time during the 24 hours of the day, provided there is sexual stimulation. Tadalafil Krka administered daily may be useful in men who anticipate having sexual activity two or more times a week.
It is essential to note that Tadalafil Krka is not effective if there is no sexual stimulation. Therefore, you and your partner should stimulate each other in the same way as you would if you were not taking a medication for erectile dysfunction.
Consuming alcohol may affect your ability to have an erection.
For the treatment of benign prostatic hyperplasia
The doseis one 5 mg tablet once a day, approximately at the same time.
If you have benign prostatic hyperplasia and erectile dysfunction, the dose remains one 5 mg tablet once a day.
Do not take Tadalafil Krka more than once a day.
If you take more Tadalafil Krka than you should
Consult your doctor. You may experience side effects described in section 4.
In case of overdose or accidental ingestion, consult the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount taken. It is recommended to take the packaging and the package leaflet of the medication to the healthcare professional.
If you forget to take Tadalafil Krka
Take your dose as soon as you remember, but do not take a double dose to make up for the missed doses. Do not take Tadalafil Krka more than once a day.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone gets them. These effects are generally mild to moderate.
If you experience any of the following side effects, stop using the medication and seek medical help immediately:
Other side effects that have been reported:
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Infarction and stroke have also been reported rarely in men taking tadalafil. Most of these men had pre-existing heart problems before taking this medication.
Rarely, cases of decreased or lost vision, partial, transient, or permanent in one or both eyes have been reported.
Some additional rare side effectshave been reported in men taking tadalafil that were not observed during clinical trials. These include:
In men over 75 years of age treated with tadalafil, the most frequently reported side effects were dizziness. In men over 65 years of age treated with tadalafil, the most frequently reported side effect was diarrhea.
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date stated on the carton and blister after "EXP". The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE collection point in the pharmacy. Ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
See section 2 "Tadalafilo Krka contains lactose and sodium".
Appearance and packaging of the product
Tadalafilo Krka 5 mg film-coated tablets (tablets) are: light yellow, biconvex, oval, film-coated tablets, scored on one side and marked with a 5 on the other side, tablet dimensions: approximately 9 mm long and 6 mm wide.
The tablet can be divided into equal doses.
Tadalafilo Krka is available in packs containing 2, 4, 8, 12, 14, 28, 56, and 84 film-coated tablets in blisters.
Only some pack sizes may be marketed.
Marketing authorisation holder
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Manufacturer
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
You can request more information about this medicinal product by contacting the local representative of the marketing authorisation holder:
KRKA Farmacéutica, S.L., C/ Anabel Segura 10, Pta. Baja, Oficina 1, 28108 Alcobendas, Madrid, Spain
This pharmaceutical product is authorised in the EEA member states under the following names:
Member state | Name |
SI | Tadalafil Krka 5 mg, Filmsko obložena tableta |
AT | Tadalafil Krka 5 mg, Filmtabletten |
BE | Tadalafil Krka 5 mg, Comprimé pelliculé |
DK | Tadalafil Krka, 5 mg Filmovertrukket tablet |
ES | Tadalafilo Krka 5 mg film-coated tablet |
FI | Tadalafil Krka 5 mg, Tabletti, kalvopäällysteinen |
FR | Tadalafil Krka 5 mg, Comprimé pelliculé |
IE | Tadalafil Krka 5 mg, Film-coated tablets |
IS | Tadalafil Krka 5 mg, filmuhúðuð tafla |
IT | Tadalafil Krka |
NO | Tadalafil Krka |
PT | Tadalafil Krka |
SE | Tadalafil Krka 5 mg, Filmdragerad tablett |
UK | Tadalafil Krka 5 mg, Film-coated tablets |
Date of last revision of this leaflet:11/2024
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/